Inspire Medical Systems Inc expected to post a loss of 14 cents a share - Earnings Preview

Inspire Medical Systems

03/08/2024 03:53

* Inspire Medical Systems Inc  INSP.N   INSP.K  is expected
to show a rise in quarterly revenue when it reports  results on
August 6 for the period ending January 1 0001
    * The Golden Valley Minnesota-based  company is expected to
report
a 25.4% increase in revenue to $189.46 million from $151.09
million a year ago, according to the mean estimate from 17
analysts, based on LSEG data.The company's guidance on July 29
2024, for the period ended June 30, was for revenue of $195.900
million.
    * ​LSEG's mean analyst estimate for Inspire Medical Systems
Inc is
for a loss of 14 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 7
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Inspire
Medical
Systems Inc is $225.00​, above​ its last closing price
of $149.63. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.62       -0.65      -0.34     Beat    47.8
 Dec. 31 2024  -0.03       -0.09      0.49      Beat    653.2
 Sep. 30 2023  -0.53       -0.58      -0.29     Beat    50​
 Jun. 30 2023  -0.54       -0.57      -0.41     Beat    28
 ​​Mar.        -0.67       -0.66      -0.53     Beat    19.7
 31 2023                                                
 Jan. 1 0001   -0.48                  0.10              117.7​
 Sep. 30 2022  -0.74       -0.77      -0.60     Beat    21.7
 Jan. 1 0001   -0.61       -0.62      -0.53     Beat    14.3
 This summary was machine generated August 3 at 02:52 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)